Sacral neuromodulation, also known as sacral nerve stimulation, is a
type of electrical stimulation. Sacral neuromodulation system is an
implanted system that can help improve the functioning of the bladder
by sending electrical signals to the nerves, which control bladder
activities. According to a study on neuromodulation devices and
therapies, neuromodulation is a safe, effective, and long term
treatment for chronic pain and movement disorders. Neuromodulation
technology is gaining momentum in biotechnology, led by its extensive
therapeutic scope. It is primarily used as a treatment for
unmanageable chronic pain or movement conditions. Sacral nerve
stimulation is a treatment used for the overactive bladder. It is
vital when a person is unable to voluntary control bodily functions
of urination. It is a condition wherein there is unintentional loss
of urine from body. In some cases, sacral neuromodulation effectively
treats fecal incontinence. Sacral neuromodulation is a process,
wherein small electrodes are placed under the skin where the bladder
nerves are present. These electrodes are attached to a small device,
which can help restore the normal function of the bladder. This
device can be easily removed by the concerned individual or a
physician; it can also be placed permanently if necessary.
Report Overview @
https://www.transparencymarketresearch.com/sacral-neuromodulation-systems-market.html
Sacral neuromodulation is a minimally invasive and reversible
process. The procedure is anticipated to be a treatment for
overreacting bladder symptoms including urgency frequency syndrome
(it is a form of voiding dysfunction characterized by an uncontrolled
urge to void, resulting in frequent urine voided than is normally
expected) and urge urinary incontinence (involuntary leakage of
urine) for patients who cannot tolerate conservative treatments.
Sacral neuromodulation provides sustainable symptom relief in
carefully-selected patients, thereby avoiding repeated treatment with
botulinum toxin A or irreversible surgery.
Chronic pain or movement dysfunction are not life threatening
disorder; however, it may negative affect the patient’s quality of
life by hampering the ability to work and function socially. Many
patients with incontinence feel uncomfortable sharing their problem
with physicians, thus posing a major challenge to identify the rate
of incidence. However, increase in medical campaigns about these
conditions and changing demographics are expected to fuel the demand
for incontinence products. Other options such as physiotherapy and
pelvic floor exercises, drug treatment (tablets), and bladder
re-training can be uses as alternative treatments.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28247
Permanent treatment options such as bladder enlargement or
replacement using bowel, and urinary diversion into the stoma are
also available. However, the sacral neuromodulation method is gaining
popularity among patients with lower urinary tract symptoms and
pelvic organ prolapse, as it is safer than other surgical methods
such as augmentation cystoplasty. The high cost of implant is
anticipated to hamper the sacral neuromodulation systems market.
However, proven efficacy and lack of other acceptable treatment
methods are estimated to boost the sacral neuromodulation systems
market, particularly in developing regions across the world.
Based on geography, the global sacral neuromodulation systems market
can be segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America is expected to
be a key region of the market, due to the high obesity rate and
increase in stress incontinence. Europe is projected to follow North
America owing to the presence of large number of aging population in
the region. The prevalence of urinary incontinence and overactive
bladder increases with age. However, the market in Asia is likely to
expand at a rapid pace due to the rise in awareness about newly
advanced healthcare treatments, gradual rise in adoption of improved
technologies, growth in health care infrastructure, increase in
purchasing power of end user’s and rising population.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=28247<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment